Baricitinib not linked to adverse cardiovascular outcomes in RA - Healio

Baricitinib not linked to adverse cardiovascular outcomes in RA  Healio

Baricitinib demonstrated no association with major adverse cardiovascular or venous thromboembolic events among patients with rheumatoid arthritis, ...